Details

Autor(en) / Beteiligte

• Locci, Sara
• Cardani, Rosanna
• Brunori, Paola
• Lucchiari, Sabrina
• Comi, Giacomo P.
• Federico, Antonio
• De Stefano, Nicola
• Meola, Giovanni
• Mignarri, Andrea

Titel

Co-occurrence of DMPK expansion and CLCN1 mutation in a patient with myotonia

Ist Teil von

• Neurological sciences, 2021-12, Vol.42 (12), p.5365-5368

Ort / Verlag

Cham: Springer International Publishing

Erscheinungsjahr

2021

Quelle

SpringerLink

Beschreibungen/Notizen

• Introduction Myotonic disorders are a group of diseases affecting the muscle, in different ways. Myotonic dystrophy type 1 (DM1) is related to (CTG)n expansion in the 3-untranslated region of the dystrophia myotonica protein kinase (DMPK) gene and is the most frequent and disabling form, causing muscular, visibility, respiratory, and cardiac impairment. Non-dystrophic myotonias (NDMs) affect the skeletal muscle alone. In particular, mutations in the chloride channel (CLCN1) gene cause myotonia congenita (MC), which can have autosomal dominant or recessive inheritance. Case report We describe a patient with a family history of asymptomatic or paucisymptomatic myotonia, who presented handgrip myotonia which sharply reduced after mexiletine administration. Molecular analysis showed both a paternally inherited DMPK expansion and a maternally inherited CLCN1 mutation. Conclusions Only one other similar case was reported so far; however, the segregation of the two mutations and the characteristics of the muscle were not studied. Since our patient lacked the classical phenotypical and muscle histopathological characteristics of DM1 and showed mild splicing alterations despite a pathogenic DMPK expansion and the nuclear accumulation of toxic RNA, we may speculate that the co-occurrence of a CLCN1 mutation could have attenuated the severity of DM1 phenotype.